Related Experiment Video
Updated: Jun 8, 2026
Intracameral Injection in Rats with Low Risk of Adverse Effects
Published on: May 31, 2024
Intracameral triamcinolone acetonide after pediatric cataract surgery
Catherine A Cleary1, Bernadette Lanigan, Michael O'Keeffe
1Doheny Eye Institute, University of Southern California, Los Angeles, California, USA.
Purpose:
To assess the use of preservative-free intracameral triamcinolone as an adjunct to topical steroidal agents after pediatric cataract surgery.
Setting:
Children's University Hospital, Dublin, Ireland.
Design:
Retrospective case series.
Methods:
From the 2008 to 2009, intracameral preservative-free triamcinolone 4 mg/0.1 mL (Triesence) was used immediately after cataract surgery. Clinical indices of anterior segment inflammation were assessed at 1, 7, 14, 21 days and at 6 weeks postoperatively.
Results:
There were no complications secondary to triamcinolone use in 36 eyes of 26 children. In all but 1 case, intracameral triamcinolone was highly effective in controlling postoperative inflammation after pediatric cataract surgery, resulting in quiet eyes with few inflammatory signs (grade 0 to 1).
Conclusion:
Intracameral triamcinolone provided a safe and useful adjunct to topical steroid drops after pediatric cataract surgery.
